Press Release
Select category
  • Select category
  • Aerospace & Defense
    • Aircraft Components
    • Aircraft Material
    • Aviation
    • Defense
    • Marine
    • Security
    • Space
    • Technology
  • Agriculture
    • Materials
    • Technology
  • Automotive
    • Automotive Systems
    • Chemical Automotive
    • Component
    • Freight & Logistics
    • Material
    • Technology
    • Transport Mode
    • Utility
    • Vehicle
  • Automotive (CI)
  • Baby Products and supplies
  • BFSI
    • Banking
  • Chemical and Materials
    • Advanced Materials
    • Chemical
    • Coatings and Additives
    • Composites
    • Paints
    • Textile
  • Chemical and Materials (CI)
  • Construction & Manufacturing
    • Agriculture
    • Construction and Improvements
    • Construction Materials
    • Decor
    • Equipment and Machinery
    • Industrial Equipment & Automation
    • Packaging
  • Construction & Manufacturing (CI)
  • Consumer & Goods
    • Baby products and supplies
    • Beauty & Personal Care
    • Consumer
    • Home Products
    • Retail
    • Sports & Fitness
    • Travel
  • Electronics and Semiconductor
    • Communication Equipment
    • Display Technology
    • Electronic Component
    • Electronic Devices
    • Emerging Technologies
    • Security
    • Semiconductor
    • Sensor & Control
    • Technology
  • Electronics and Semiconductor (CI)
  • Energy and Power
    • Conventional Energy
    • Equipment
    • Power
    • Renewable Energy
    • Services
    • Storage and Distribution
    • Technology
    • Utility
  • Energy and Power (CI)
  • Food & Beverage
    • Baby Food
    • Beverages
    • Dairy Products
    • Food Ingredient
    • Food Products
    • Food Services and Hospitality
    • Packaging
    • Processed Food
  • Healthcare
  • Healthcare (CI)
  • Industrial Automation & Equipment
    • Component
  • Information and Communication Technology
    • Communication
    • Data Center
    • Data Center and Networking
    • Emerging Technologies
    • Entertainment Technologies
    • Security
    • Software and Services
    • Technology
  • Information and Communication Technology ICT (CI)
  • Life Science
    • Biotechnology
    • Diagnostics and Biotech
    • Healthcare Equipment
    • Healthcare IT
    • Medical Devices
    • Packaging
    • Pharmaceutical
    • Therapeutic
  • Miscellaneous
    • BFSI
    • Education and Training
  • Uncategorized
Evolve Business Intelligence Evolve Business Intelligence
  • Home
  • About Us
  • Services
  • Market Reports
    • Automotive
      • Component
      • Vehicle
      • Chemical Automotive
      • Technology
      • Freight & Logistics
      • Material
      • Technology
      • Transport Mode
      • Utility
      • Vehicle
    • Chemical and Materials
      • Chemical
      • Advanced Materials
      • Coatings and Additives
      • Composites
      • Paints
      • Textile
    • Aerospace & Defense
      • Marine
      • Security
      • Technology
      • Aircraft Components
      • Aircraft Material
    • Construction & Manufacturing
    • Electronics and Semiconductor
      • Display Technology
      • Electronic Component
      • Electronic Devices
      • Semiconductor
      • Communication Equipment
      • Emerging Technologies
      • Security
      • Sensor & Control
      • Technology
    • Energy and Power
    • Life Science
    • Consumer & Goods
      • Baby products and supplies
      • Beauty & Personal Care
      • Consumer
      • Home Products
    • Information and Communication Technology
      • Emerging Technologies
      • Entertainment Technologies
      • Security
      • Communication
      • Data Center
      • Data Center and Networking
      • Software and Services
      • Technology
  • Competitive Intelligence (CI)
    • Automotive (CI)
    • Chemical and Materials (CI)
    • Construction & Manufacturing (CI)
    • Energy and Power (CI)
    • Electronics and Semiconductor (CI)
    • Healthcare (CI)
    • Information and Communication Technology ICT (CI)
  • Contact Us
Menu
Evolve Business Intelligence Evolve Business Intelligence
Press Release
Life Science
Click to enlarge
Home » Our Report Repository » Allergic Rhinitis Market Analysis and Global Forecast (2023-2033) with COVID Impact Analysis
Life Science
Post Traumatic Stress Disorder (PTSD) Market Analysis and Forecast $ 3,475.00
Back to products
Life Science
Life Science Analytics Market Analysis and Global Forecast (2023-2033) with COVID Impact Analysis $ 3,475.00

Allergic Rhinitis Market Analysis and Global Forecast (2023-2033) with COVID Impact Analysis

$ 3,475.00

Allergic Rhinitis Market Research Report: Information By Drug Class (Antihistamines, Intranasal cortico steroids, Immuno therapies), By Route of Administration (Oral, Parenteral, Intranasal), By Form (Solid, Liquid), and By Region — Forecast till 2033.

Press Release: https://evolvebi.com/desiccant-air-breathers-market-is-estimated-to-record-a-cagr-of-around-5-58-during-the-forecast-period/

Categories: Life Science, Therapeutic
Share:
  • Description
  • Table of content
  • Connect to Analyst
  • Research Methodology
Description

Allergic Rhinitis Market Overview

The Global Allergic Rhinitis Market Size is expected to reach USD 22.32 Billion by 2033. The global Allergic Rhinitis industry size accounted for USD 14.75 billion in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 4.12% from 2023 to 2033.Allergic rhinitis is a chronic condition that can be seasonal or perennial, depending on the type of allergen and individual sensitivity. Seasonal allergic rhinitis is usually triggered by airborne allergens that are prevalent during specific times of the year, such as tree pollen in the spring, grass pollen in the summer, and weed pollen in the fall. Perennial allergic rhinitis, on the other hand, can occur year-round and is often triggered by indoor allergens, such as dust mites, pet dander, and mold spores. Treatment for allergic rhinitis may include allergen avoidance, medication such as antihistamines, decongestants, nasal cortico steroids, and immune therapy (allergy shots) for severe cases. It’s important to consult a healthcare professional for an accurate diagnosis and appropriate treatment plan tailored to individual needs.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a multi-faceted impact on the Allergic Rhinitis market, with changes in patient behavior, disruptions in healthcare services, economic challenges, and shifts in research and development efforts. The full extent of the impact may continue to evolve as the pandemic situation changes and further research is conducted. It is important to consult with healthcare professionals and stay updated with the latest information and guidelines for the management of Allergic Rhinitis during the pandemic.

Allergic Rhinitis Market Dynamics

The major factors that have impacted the growth of Allergic Rhinitis are as follows:

Drivers:

  •  Growing awareness and diagnosis of allergic

Awareness about allergic rhinitis has been raised through various channels, including public health campaigns, educational initiatives by healthcare organizations, and increased media coverage. Patients and healthcare providers are now better informed about the common symptoms of allergic rhinitis, such as sneezing, itching, nasal congestion, and a runny nose, which prompts them to seek medical attention for a proper diagnosis.Early diagnosis of allergic rhinitis allows for timely initiation of treatment, which can help in managing symptoms and preventing complications. It also helps in identifying triggers and implementing appropriate allergen avoidance strategies. As a result, there is a higher demand for medications and other treatment options to effectively manage allergic rhinitis, which drives the growth of the Allergic Rhinitis market.

Restraint:

  •   Side effects and safety concerns

Some of the medications used for allergic rhinitis, such as nasal corticosteroids and antihistamines, may have side effects such as drowsiness, dryness of the mouth or nose, and other adverse effects. This may limit their use in certain patient populations, such as children, elderly individuals, or those with specific health conditions. Safety concerns associated with the long-term use of medications may also impact patient compliance and adherence to treatment regimens, which could be a restraint for the market.

Opportunity:

  •       Increasing adoption of immuno therapy

Immuno therapy, such as subcutaneous or sublingual allergen immuno therapy, has shown promising results in managing allergic rhinitis by addressing the underlying immune response to allergens. With increasing research and clinical evidence supporting the safety and efficacy of immuno therapy, there is an opportunity for wider adoption of immuno therapy as a long-term treatment option for allergic rhinitis. This can drive the growth of the market and provide additional treatment options for patients.

Allergic Rhinitis Segment Overview

By Drug Class

Based on the Drug Class, the market is segmented based on Antihistamines, Intranasal cortico steroids, and Immuno therapies. During the projection period, the Antihistaminessegmentis expected to hold the largest market share.Antihistamines are commonly used for the treatment of Allergic Rhinitis, which is a condition characterized by inflammation of the nasal passages due to an allergic reaction. Antihistamines work by blocking the action of histamine, a chemical released by the immune system in response to allergens, thus relieving symptoms such as sneezing, itching, and a runny nose.

By Route of Administration

Based on the Route of Administration, the market has been divided into Oral, Parental, and Intranasal. The Oral segment is expected to hold the largest market share.Oral medications, including antihistamines and other classes of drugs, are commonly used for the treatment of Allergic Rhinitis. Oral antihistamines are available over-the-counter (OTC) or with a prescription, and they are typically used for mild to moderate symptoms of Allergic Rhinitis, such as sneezing, itching, and a runny nose. They work by blocking the action of histamine, a chemical released by the immune system in response to allergens.

By Form

Based on Form, the market has been divided into Solid and Liquid.The Solid segment is expected to hold the largest market share.Solid dosage forms, including oral tablets and capsules, are commonly used for the treatment of Allergic Rhinitis. Oral medications, such as antihistamines, decongestants, and nasal cortico steroids, are available in solid dosage forms and are typically used for mild to moderate symptoms of Allergic Rhinitis, including sneezing, itching, and a runny nose.

Global Allergic Rhinitis Market Share, by Segmentation

Global-Allergic-Rhintis-Market

 

 

Based on region, the global MHealth market has been divided into North America, Europe, Asia-Pacific, and the Rest of the World. North America is projected to dominate the use of the market followed by the Asia-Pacific and Europe regions.

North America Market

North America holds a significant share of the global allergic rhinitis market. Allergic rhinitis, commonly known as hay fever, is a condition characterized by inflammation of the nasal passages due to an immune response triggered by allergens such as pollen, dust mites, pet dander, and mold spores. In North America, the prevalence of allergic rhinitis is relatively high, with a large number of people suffering from seasonal or perennial allergies. The region has a well-established healthcare infrastructure and advanced diagnostic and treatment options, which contribute to the dominance of North America in the allergic rhinitis market.

Asia-Pacific Market

The Asia-Pacific region is projected to be a prominent growth market for the allergic rhinitis market. Allergic rhinitis, commonly known as hay fever, is a condition characterized by inflammation of the nasal passages due to an immune response triggered by allergens such as pollen, dust mites, pet dander, and mold spores. In recent years, there has been an increasing awareness of allergic rhinitis in the Asia-Pacific region, leading to a higher demand for diagnosis and treatment options. Rapid urbanization, changing lifestyles, and environmental factors such as increasing pollution levels and exposure to allergens are contributing to the rising prevalence of allergic rhinitis in the region. Furthermore, the growing middle-class population with higher disposable incomes and improved access to healthcare services are driving the demand for allergic rhinitis medications and treatments in the Asia-Pacific region. Increasing investments in healthcare infrastructure andthe rising adoption of advanced diagnostic and treatment technologies are also supporting the growth of the allergic rhinitis market in the region.

Competitive Landscape

The market comprises tier-1, tier-2, and local players. With their wide product portfolios, tier-1 and tier-2 players have a global reach. Since their strategic innovations and broad regional presence, companies such as Glaxo Smith Kline,Merck & Co, Johnson & Johnson, and Sanofi lead the global Allergic Rhinitis business. To increase their market position and attract a wide consumer base, the businesses are employing various strategies, such as growth, product releases, and alliances.

Prominent Players:

  • Glaxo Smith Kline
  • Sanofi
  • ALK-Abell
  • Meda Pharmaceuticals
  • Merck & Co
  • Boehringer Ingelheim
  • AstraZeneca
  • Johnson & Johnson
  • Teva Pharmaceutical Industries Ltd
  • Alcon (Novartis AG)

Key Development:

November 2022: Alcon announced the acquisition of Aerie Pharmaceuticals, Inc. This acquisition will assist Alcon in strengthening its ophthalmic medicines portfolio, which already includes several commercial products and others in the development stage.

September 2022: Glenmark Pharmaceuticals’ Ryaltris nasal spray. The utilization of this cutting-edge therapeutic approach is employed to treat severe seasonal allergic rhinitis as well as other eye problems. Through its subsidiaries Glenmark Specialty SA and Bausch Health Companies Inc., the permission is secured.

March 2021: ALK announced that the FDA had approved the use of short ragweed pollen allergen extract for the treatment of patients with short ragweed pollen-induced allergic rhinitis who are 5 to 65 years old.

Scope of the Report

Global Allergic Rhinitis Market, by Drug Class
  • Antihistamines
  • Intranasal corticosteroids
  • Immunotherapies
Global Allergic Rhinitis Market, by Route of Administration
  • Oral
  • Parenteral
  • Intranasal
Global Allergic Rhinitis Market, by Form
  • Solid
  • Liquid
Global Allergic Rhinitis Market, by Region
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Benelux
    • Nordic
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • Indonesia
    • Austalia
    • Malaysia
    • India
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of SouthAmerica
  • Middle East &Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • SouthAfrica
    • Rest of Middle East & Africa
Parameters Indicators
Market Size
2033: USD22.32Billion
CAGR
4.12% CAGR (2023-2033)
Base Year
2022
Forecast Period
2023 to 2033
Historical Data
2021
Report Coverage
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Key Segmentations
Drug Class,Route of Administration,Form
Geographies Covered
North America, Europe, Asia-Pacific, Latin America, Middle East, Africa
Key Players
GlaxoSmithKline, Sanofi, ALK-Abell, Meda Pharmaceuticals, Merck & Co., Boehringer Ingelheim, AstraZeneca, Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Alcon (Novartis AG)
Key Market Opportunities
Increasing adoption of immunotherapy
Key Market Drivers
Growing awareness and diagnosis of allergic rhinitis

REPORT CONTENT BRIEF:

  • High-level analysis of the current and future Allergic Rhinitis market trends and opportunities
  • Detailed analysis of current market drivers, restraining factors, and opportunities in the future
  • Allergic Rhinitis market historical market size for the year 2021, and forecast from 2023 to 2033
  • Allergic Rhinitis market share analysis at each product level
  • Competitor analysis with a detailed insight into its product segment, financial strength, and strategies adopted.
  • Identifies key strategies adopted including product launches and developments, mergers and acquisitions, joint ventures, collaborations, and partnerships as well as funding taken and investment done, among others.
  • To identify and understand the various factors involved in the global Allergic Rhinitis market affected by the pandemic
  • To provide a detailed insight into the major companies operating in the market. The profiling will include the financial health of the company’s past 2-3 years with segmental and regional revenue breakup, product offering, recent developments, SWOT analysis, and key strategies.

Frequently Asked Questions (FAQ)

For more details mail us at

[email protected]

Ask a question / additional requirement

Press Release

  • The Global Double Chamber Injection Devices Market Is Estimated To Record a CAGR of Around 9.99% During The Forecast Period

    The Global Double Chamber Injection Devices Market Is Estimated To Record a CAGR of Around 9.99% During The Forecast Period

    August 26, 2023

  • The Global Flexible Printed Circuit Board Market Is Estimated To Record a CAGR of Around 11.60% During The Forecast Period

    The Global Flexible Printed Circuit Board Market Is Estimated To Record a CAGR of Around 11.60% During The Forecast Period

    August 26, 2023

  • The Global Clinical Biomarkers Market Is Estimated To Record a CAGR of Around 16.7% During The Forecast Period

    The Global Clinical Biomarkers Market Is Estimated To Record a CAGR of Around 16.7% During The Forecast Period

    August 26, 2023

  • The Global Data Center Environmental Monitoring System Market Is Estimated To Record a CAGR of Around 8.45% During The Forecast Period

    The Global Data Center Environmental Monitoring System Market Is Estimated To Record a CAGR of Around 8.45% During The Forecast Period

    August 26, 2023

  • The Global Data Center Networking Market Is Estimated To Record a CAGR of Around 15.55% During The Forecast Period

    The Global Data Center Networking Market Is Estimated To Record a CAGR of Around 15.55% During The Forecast Period

    August 26, 2023

  • The Global Graft Delivery Device Market Is Estimated To Record a CAGR of Around 12.99% During The Forecast Period

    The Global Graft Delivery Device Market Is Estimated To Record a CAGR of Around 12.99% During The Forecast Period

    August 26, 2023

  • The Global HubSpot Consulting and Implementation Market Is Estimated To Record a CAGR of Around 15.23% During The Forecast Period

    The Global HubSpot Consulting and Implementation Market Is Estimated To Record a CAGR of Around 15.23% During The Forecast Period

    August 26, 2023

  • The Global Liquid Skin Protectors Market Is Estimated To Record a CAGR of Around 10.64% During The Forecast Period

    The Global Liquid Skin Protectors Market Is Estimated To Record a CAGR of Around 10.64% During The Forecast Period

    August 26, 2023

  • The Global Lithium-Ion Battery Energy Storage System Market Is Estimated To Record a CAGR of Around 15.5% During The Forecast Period

    The Global Lithium-Ion Battery Energy Storage System Market Is Estimated To Record a CAGR of Around 15.5% During The Forecast Period

    August 26, 2023

  • The Global Machine Safety Market Is Estimated To Record a CAGR of Around 6.9% During The Forecast Period

    The Global Machine Safety Market Is Estimated To Record a CAGR of Around 6.9% During The Forecast Period

    August 26, 2023

  • Global generative AI market

    Generative AI Market Analysis and Global Forecast (2023-2033) with COVID Impact Analysis

    Generative AI Market Research Report: By Offerings (Hardware, Software, Services), By Application (Natural Language Processing, ML-based Predictive Modeling, Computer Vision, Robotics and Automation, Others), By Verticals (Media & Entertainment, Transportation and Logistics, Manufacturing, Healthcare & Life Science, IT and ITES, Others), and by Region — Forecast till 2033

  • Global Flameless LED candles

    Manuka Honey Market Analysis and Global Forecast (2023-2033) with COVID Impact Analysis

    Manuka Honey Market Research Report: Information By Type (UMF 5+, UMF 10+, UMF 15+, UMF 20+), By Nature (Organic/Natural, Conventional), By Application (Nutraceutical, Pharmaceutical, Others) and By Region — Forecast till 2033

  • Global generative AI market

    Machine Safety Market Analysis and Global Forecast (2023-2033) with COVID Impact Analysis

    Machine Safety Market Research Report: Information By Component (Safety Sensors, On-Safety Interlock Switches, Safety Controller, and Others), By Implementation (Individual, Embedded), By Industry Vertical (Oil and Gas, Healthcare, Automotive, Metals and Mining, and Other Industry Verticals) and By Region — Forecast till 2033

  • Energy and Power

    Lithium-Ion Battery Energy Storage System Market Analysis and Global Forecast (2023-2033) with COVID Impact Analysis

    Lithium-Ion Battery Energy Storage System Market Overview The global Lithium-Ion Battery Energy Storage System Market Size is expected to reach
  • Life Science

    Liquid Skin Protectors Market Analysis and Global Forecast (2023-2033) with COVID Impact Analysis

    Liquid Skin Protectors Market Research Report: Information By Type (Liquid, Spray), By Application (Liquid Skin Protectors, Daily Wound Management), and By Region — Forecast till 2033

What is the study period of this market?

The study period of the global Allergic Rhinitis market is 2022- 2033

What is the growth rate of the global Allergic Rhinitis market?

The global Allergic Rhinitis market is growing at a CAGR of ~4.12% over the next 10 years

Which region has the highest growth rate in the market of Allergic Rhinitis?

Asia Pacific is expected to register the highest CAGR during 2023-2033

Which region has the largest share of the global Allergic Rhinitis market?

North America holds the largest share in 2022

Who are the key players in the global Allergic Rhinitis market?

GlaxoSmithKline, Sanofi, ALK-Abell, Meda Pharmaceuticals, Merck & Co., Boehringer Ingelheim, AstraZeneca, Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Alcon (Novartis AG)are the major companies operating in the market.

Do you offer Post Sale Support?

Yes, we offer 16 hours of analyst support to solve the queries

Do you sell particular sections of a report?

Yes, we provide regional as well as country-level reports. Other than this we also provide a sectional report. Please get in contact with our sales representatives.

Table of content

Table of content

Table of Content

CHAPTER 1.                 Executive Summary

CHAPTER 2.                 Scope of the Study

2.1.        Market Definition

2.2.        Market Scope & Segmentation

2.2.1.         Objective of Report

CHAPTER 3.                 Evolve BI Methodology

3.1.        Data Collection & Validation Approach

3.2.        Market Size Estimation and Forecast

CHAPTER 4.                 Exclusive Analysis

4.1.        Market Opportunity Score

4.1.1.         Drug Class Segement – Market Opportunity Score

4.1.2.         Route of Administration Segment – Market Opportunity Score

4.1.3.         Form Segment – Market Opportunity Score

4.2.        Key Market Influencing Indicators

CHAPTER 5.                 Market Insights and Trends

5.1.        Value Chain Analysis

5.1.1.         Raw Material

5.1.2.         Manufacturing Process

5.1.3.         Distribution Channel

5.1.4.         End User

5.2.        Porter’s Five Forces Analysis

5.2.1.         Bargaining Power of Buyers

5.2.2.         Bargaining Power of Suppliers

5.2.3.         Threat of New Entrant

5.2.4.         Threat of Substitute

5.2.5.         Industry Rivalry

5.3.        COVID-19 Impact and Post COVID Scenario on Allergic Rhinitis Market

5.3.1.         Impact of COVID-19

5.3.2.         Government Support and Industry Revival Policies

5.3.3.         Measures Taken by Companies to Mitigate Negative Impact

5.3.4.         Post COVID Trend

CHAPTER 6.                 MArket Dynamics

6.1.        Introduction

6.2.        Drivers

6.2.1.         Driver 1

6.2.2.         Driver 2

6.2.3.         Driver 3

6.3.        Restraints

6.3.1.         Restraint 1

6.3.2.         Restraint 2

6.4.        Opportunity

6.4.1.         Opportunity 1

CHAPTER 7.                 Global Allergic Rhinitis Market, By Drug Class

7.1.        Introduction

7.1.1.         Antihistamines

7.1.2.         Intranasal corticosteroids

7.1.3.         Immunotherapies

CHAPTER 8.                 Global Allergic Rhinitis Market, By Route of Administration

8.1.        Introduction

8.1.1.         Oral

8.1.2.         Parenteral

8.1.3.         Intranasal

CHAPTER 9.                 Global Allergic Rhinitis Market, By Form

9.1.        Introduction

9.1.1.         Solid

9.1.2.         Liquid

CHAPTER 10.               Global Allergic Rhinitis Market, By Region

10.1.     Introduction

10.2.     NORTH AMERICA

10.2.1.      North America: Market Size and Forecast, By Country, 2021 – 2033 ($ Million)

10.2.2.      North America: Market Size and Forecast, By Drug Class, 2021 – 2033 ($ Million)

10.2.3.      North America: Market Size and Forecast, By Route of Administration, 2021 – 2033 ($ Million)

10.2.4.      North America: Market Size and Forecast, By Form, 2021 – 2033 ($ Million)

10.2.5.      US

10.2.5.1.       US: Market Size and Forecast, By Drug Class, 2021 – 2033 ($ Million)

10.2.5.2.       US: Market Size and Forecast, By Route of Administration, 2021 – 2033 ($ Million)

10.2.5.3.       US: Market Size and Forecast, By Form, 2021 – 2033 ($ Million)

10.2.6.      CANADA

10.2.6.1.       Canada: Market Size and Forecast, By Drug Class, 2021 – 2033 ($ Million)

10.2.6.2.       Canada: Market Size and Forecast, By Route of Administration, 2021 – 2033 ($ Million)

10.2.6.3.       Canada: Market Size and Forecast, By Form, 2021 – 2033 ($ Million)

10.2.7.      MEXICO

10.2.7.1.       Mexico: Market Size and Forecast, By Drug Class, 2021 – 2033 ($ Million)

10.2.7.2.       Mexico: Market Size and Forecast, By Route of Administration, 2021 – 2033 ($ Million)

10.2.7.3.       Mexico: Market Size and Forecast, By Form, 2021 – 2033 ($ Million)

10.3.     Europe

10.3.1.      Europe: Market Size and Forecast, By Country, 2021 – 2033 ($ Million)

10.3.2.      Europe: Market Size and Forecast, By Drug Class, 2021 – 2033 ($ Million)

10.3.3.      Europe: Market Size and Forecast, By Route of Administration, 2021 – 2033 ($ Million)

10.3.4.      Europe: Market Size and Forecast, By Form, 2021 – 2033 ($ Million)

10.3.5.      U.K.

10.3.5.1.       U.K.: Market Size and Forecast, By Drug Class, 2021 – 2033 ($ Million)

10.3.5.2.       U.K.: Market Size and Forecast, By Route of Administration, 2021 – 2033 ($ Million)

10.3.5.3.       U.K.: Market Size and Forecast, By Form, 2021 – 2033 ($ Million)

10.3.6.      GERMANY

10.3.6.1.       Germany: Market Size and Forecast, By Drug Class, 2021 – 2033 ($ Million)

10.3.6.2.       Germany: Market Size and Forecast, By Route of Administration, 2021 – 2033 ($ Million)

10.3.6.3.       Germany: Market Size and Forecast, By Form, 2021 – 2033 ($ Million)

10.3.7.      FRANCE

10.3.7.1.       France: Market Size and Forecast, By Drug Class, 2021 – 2033 ($ Million)

10.3.7.2.       France: Market Size and Forecast, By Route of Administration, 2021 – 2033 ($ Million)

10.3.7.3.       France: Market Size and Forecast, By Form, 2021 – 2033 ($ Million)

10.3.8.      ITALY

10.3.8.1.       Italy: Market Size and Forecast, By Drug Class, 2021 – 2033 ($ Million)

10.3.8.2.       Italy: Market Size and Forecast, By Route of Administration, 2021 – 2033 ($ Million)

10.3.8.3.       Italy: Market Size and Forecast, By Form, 2021 – 2033 ($ Million)

10.3.9.           SPAIN

10.3.9.1.        Spain: Market Size and Forecast, By Drug Class, 2021 – 2033 ($ Million)

10.3.9.2.        Spain: Market Size and Forecast, By Route of Administration, 2021 – 2033 ($ Million)

10.3.9.3.        Spain: Market Size and Forecast, By Form, 2021 – 2033 ($ Million)

10.3.10.         BENELUX

10.3.10.1.     BeNeLux: Market Size and Forecast, By Drug Class, 2021 – 2033 ($ Million)

10.3.10.2.     BeNeLux: Market Size and Forecast, By Route of Administration, 2021 – 2033 ($ Million)

10.3.10.3.     BeNeLux: Market Size and Forecast, By Form, 2021 – 2033 ($ Million)

10.3.11.         RUSSIA

10.3.11.1.     Russia: Market Size and Forecast, By Drug Class, 2021 – 2033 ($ Million)

10.3.11.2.     Russia: Market Size and Forecast, By Route of Administration, 2021 – 2033 ($ Million)

10.3.11.3.     Russia: Market Size and Forecast, By Form, 2021 – 2033 ($ Million)

10.3.12.         REST OF EUROPE

10.3.12.1.     Rest of Europe: Market Size and Forecast, By Drug Class, 2021 – 2033 ($ Million)

10.3.12.2.     Rest of Europe: Market Size and Forecast, By Route of Administration, 2021 – 2033 ($ Million)

10.3.12.3.     Rest of Europe: Market Size and Forecast, By Form, 2021 – 2033 ($ Million)

10.4.     Asia Pacific

10.4.1.      Asia Pacific: Market Size and Forecast, By Country, 2021 – 2033 ($ Million)

10.4.2.      Asia Pacific: Market Size and Forecast, By Drug Class, 2021 – 2033 ($ Million)

10.4.3.      Asia Pacific: Market Size and Forecast, By Route of Administration, 2021 – 2033 ($ Million)

10.4.4.      Asia Pacific: Market Size and Forecast, By Form, 2021 – 2033 ($ Million)

10.4.5.      CHINA

10.4.5.1.       China: Market Size and Forecast, By Drug Class, 2021 – 2033 ($ Million)

10.4.5.2.       China: Market Size and Forecast, By Route of Administration, 2021 – 2033 ($ Million)

10.4.5.3.       China: Market Size and Forecast, By Form, 2021 – 2033 ($ Million)

10.4.6.      JAPAN

10.4.6.1.       Japan: Market Size and Forecast, By Drug Class, 2021 – 2033 ($ Million)

10.4.6.2.       Japan: Market Size and Forecast, By Route of Administration, 2021 – 2033 ($ Million)

10.4.6.3.       Japan: Market Size and Forecast, By Form, 2021 – 2033 ($ Million)

10.4.7.      INDIA

10.4.7.1.       India: Market Size and Forecast, By Drug Class, 2021 – 2033 ($ Million)

10.4.7.2.       India: Market Size and Forecast, By Route of Administration, 2021 – 2033 ($ Million)

10.4.7.3.       India: Market Size and Forecast, By Form, 2021 – 2033 ($ Million)

10.4.8.      SOUTH KOREA

10.4.8.1.       South Korea: Market Size and Forecast, By Drug Class, 2021 – 2033 ($ Million)

10.4.8.2.       South Korea: Market Size and Forecast, By Route of Administration, 2021 – 2033 ($ Million)

10.4.8.3.       South Korea: Market Size and Forecast, By Form, 2021 – 2033 ($ Million)

10.4.9.           THAILAND

10.4.9.1.        Thailand: Market Size and Forecast, By Drug Class, 2021 – 2033 ($ Million)

10.4.9.2.        Thailand: Market Size and Forecast, By Route of Administration, 2021 – 2033 ($ Million)

10.4.9.3.        Thailand: Market Size and Forecast, By Form, 2021 – 2033 ($ Million)

10.4.10.         INDONESIA

10.4.10.1.     Indonesia: Market Size and Forecast, By Drug Class, 2021 – 2033 ($ Million)

10.4.10.2.     Indonesia: Market Size and Forecast, By Route of Administration, 2021 – 2033 ($ Million)

10.4.10.3.     Indonesia: Market Size and Forecast, By Form, 2021 – 2033 ($ Million)

10.4.11.         MALAYSIA

10.4.11.1.     Malaysia: Market Size and Forecast, By Drug Class, 2021 – 2033 ($ Million)

10.4.11.2.     Malaysia: Market Size and Forecast, By Route of Administration, 2021 – 2033 ($ Million)

10.4.11.3.     Malaysia: Market Size and Forecast, By Form, 2021 – 2033 ($ Million)

10.4.12.         AUSTRALIA

10.4.12.1.     Australia: Market Size and Forecast, By Drug Class, 2021 – 2033 ($ Million)

10.4.12.2.     Australia: Market Size and Forecast, By Route of Administration, 2021 – 2033 ($ Million)

10.4.12.3.     Australia: Market Size and Forecast, By Form, 2021 – 2033 ($ Million)

10.4.13.         REST FO ASIA PACIFIC

10.4.13.1.     Rest fo Asia Pacific: Market Size and Forecast, By Drug Class, 2021 – 2033 ($ Million)

10.4.13.2.     Rest fo Asia Pacific: Market Size and Forecast, By Route of Administration, 2021 – 2033 ($ Million)

10.4.13.3.     Rest fo Asia Pacific: Market Size and Forecast, By Form, 2021 – 2033 ($ Million)

10.5.     South America

10.5.1.      South America: Market Size and Forecast, By Country, 2021 – 2033 ($ Million)

10.5.2.      South America: Market Size and Forecast, By Drug Class, 2021 – 2033 ($ Million)

10.5.3.      South America: Market Size and Forecast, By Route of Administration, 2021 – 2033 ($ Million)

10.5.4.      South America: Market Size and Forecast, By Form, 2021 – 2033 ($ Million)

10.5.5.      BRAZIL

10.5.5.1.       Brazil: Market Size and Forecast, By Drug Class, 2021 – 2033 ($ Million)

10.5.5.2.       Brazil: Market Size and Forecast, By Route of Administration, 2021 – 2033 ($ Million)

10.5.5.3.       Brazil: Market Size and Forecast, By Form, 2021 – 2033 ($ Million)

10.5.6.      ARGENTINA

10.5.6.1.       Argentina: Market Size and Forecast, By Drug Class, 2021 – 2033 ($ Million)

10.5.6.2.       Argentina: Market Size and Forecast, By Route of Administration, 2021 – 2033 ($ Million)

10.5.6.3.       Argentina: Market Size and Forecast, By Form, 2021 – 2033 ($ Million)

10.5.7.      REST OF SOUTH AMERICA

10.5.7.1.       Rest of South America: Market Size and Forecast, By Drug Class, 2021 – 2033 ($ Million)

10.5.7.2.       Rest of South America: Market Size and Forecast, By Route of Administration, 2021 – 2033 ($ Million)

10.5.7.3.       Rest of South America: Market Size and Forecast, By Form, 2021 – 2033 ($ Million)

10.6.     Middle East & Africa

10.6.1.      Middle East & Africa: Market Size and Forecast, By Country, 2021 – 2033 ($ Million)

10.6.2.      Middle East & Africa: Market Size and Forecast, By Drug Class, 2021 – 2033 ($ Million)

10.6.3.      Middle East & Africa: Market Size and Forecast, By Route of Administration, 2021 – 2033 ($ Million)

10.6.4.      Middle East & Africa: Market Size and Forecast, By Form, 2021 – 2033 ($ Million)

10.6.5.      SAUDI ARABIA

10.6.5.1.       Saudi Arabia: Market Size and Forecast, By Drug Class, 2021 – 2033 ($ Million)

10.6.5.2.       Saudi Arabia: Market Size and Forecast, By Route of Administration, 2021 – 2033 ($ Million)

10.6.5.3.       Saudi Arabia: Market Size and Forecast, By Form, 2021 – 2033 ($ Million)

10.6.6.      UAE

10.6.6.1.       UAE: Market Size and Forecast, By Drug Class, 2021 – 2033 ($ Million)

10.6.6.2.       UAE: Market Size and Forecast, By Route of Administration, 2021 – 2033 ($ Million)

10.6.6.3.       UAE: Market Size and Forecast, By Form, 2021 – 2033 ($ Million)

10.6.7.      EGYPT

10.6.7.1.       Egypt: Market Size and Forecast, By Drug Class, 2021 – 2033 ($ Million)

10.6.7.2.       Egypt: Market Size and Forecast, By Route of Administration, 2021 – 2033 ($ Million)

10.6.7.3.       Egypt: Market Size and Forecast, By Form, 2021 – 2033 ($ Million)

10.6.8.      SOUTH AFRICA

10.6.8.1.       South Africa: Market Size and Forecast, By Drug Class, 2021 – 2033 ($ Million)

10.6.8.2.       South Africa: Market Size and Forecast, By Route of Administration, 2021 – 2033 ($ Million)

10.6.8.3.       South Africa: Market Size and Forecast, By Form, 2021 – 2033 ($ Million)

10.6.9.           REST OF MIDDLE EAST & AFRICA

10.6.9.1.        Rest of Middle East & Africa: Market Size and Forecast, By Drug Class, 2021 – 2033 ($ Million)

10.6.9.2.        Rest of Middle East & Africa: Market Size and Forecast, By Route of Administration, 2021 – 2033 ($ Million)

10.6.9.3.        Rest of Middle East & Africa: Market Size and Forecast, By Form, 2021 – 2033 ($ Million)

CHAPTER 12.               Competitive Landscape

12.1.     Competitior Benchmarking 2023

12.2.     Market Share Analysis

12.3.     Key Developments Analysis By Top 5 Companies

12.4.     Market Share Acquisition Strategies: Analysis of Key Approaches Employed by Top Players

CHAPTER 13.               Company Profiles

13.1.     GlaxoSmithKline

13.1.1.      Business Overview

13.1.2.      Financial Analysis

13.1.2.1.       Business Segment Revenue, 2020, 2021, 2022, $ Million

13.1.2.2.       Geographic Revenue Mix, 2022 (% Share)

13.1.3.      Drug Class Portfolio

13.1.4.      Recent Development and Strategies Adopted

13.1.5.      SWOT Analysis

13.2.     Sanofi

13.3.     ALK-Abell

13.4.     Meda Pharmaceuticals

13.5.     Merck & Co

13.6.     Boehringer Ingelheim

13.7.     AstraZeneca

13.8.     Johnson & Johnson

13.9.     Teva Pharmaceutical Industries Ltd

13.10.Alcon (Novartis AG)

 

Connect to Analyst

Connect to Analyst

Research Methodology

Research Methodology

Related products

Healthcare

Global Healthcare Blockchain Technology Market

$ 3,475.00
Healthcare Blockchain Technology Market By Type (Public and Private) By Application (Clinical Data Exchange & Interoperability, Claims Adjudication & Billing, Supply Chain Management, and Others) By End Use (Hospitals, Healthcare Payers, Healthcare Providers, Pharmaceutical Companies, and Others) and By Geography: Global trends, opportunities and forecast – 2020 to 2026
Add to cart
Quick view
Life Science

Clinical Decision Support Systems Market Analysis and Global Forecast (2020-2028) with COVID Impact Analysis

$ 3,475.00

Clinical Decision Support Systems Market By Product Type (Integrated CDSS, Standalone CDSS), By Application (Advanced CDSS, Conventional CDSS) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2028

Report Code: EB_LS_339 | Page: 169 | Published Date: March 2021
Add to cart
Quick view
Life Science

Proteinase K Market Analysis and Global Forecast (2020-2027) with COVID Impact Analysis

$ 3,475.00
Proteinase K Market By Type (Natural, Recombinant), Form Factor (Liquid, Powder, Tablet), End User (Bio-Pharmaceutical, Pharmaceutical, Academic and Research Centers, Hospitals, Contract Research Organization, Diagnostic Laboratories) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2020 to 2027 Report Code: EB_LS_451 | Page: 124| Published Date: March 2021
Add to cart
Quick view
Life Science

Pain Management Drugs Market Analysis and Forecast (2021-2028) with COVID Impact Analysis

$ 3,475.00
Pain Management Drugs Market By Drug Class(NSAIDs, Anesthetics, Anticonvulsants, Others), By Indication(Arthritic Pain, Neuropathic Pain, Others) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2028 Report Code: EB_LS_318| Page: 157 | Published Date: March 2021
Add to cart
Quick view
Life Science

Clinical Trial Management System Market Analysis and Global Forecast (2021-2028) with COVID Impact Analysis

$ 3,475.00

Clinical trial management system Market By Product Type (Software, Services), By End User (Medical Device Manufacturers, Small & Mid-sized Pharma-biotech Companies, CROs, Large Pharma-biotech Companies, Other End Users, Other End Users,) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2028

Report Code: EB_LS_336 | Page: 168| Published Date: March 2021
Add to cart
Quick view
Life Science

Gene Therapy Cell Culture Media Market Analysis and Forecast (2021-2028) with COVID Impact Analysis

$ 3,475.00

Gene Therapy Cell Culture Media Market By Product Type (Media, Viral Vectors), By Application (Biotechnology & Pharmaceutical Industry, Research Laboratory, Academic Institute, Others) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2028

Report Code: EB_LS_333| Page: 164 | Published Date: May 2021
Add to cart
Quick view
Life Science

India Blood Product Market Analysis and Global Forecast (2021-2027) with COVID Impact Analysis

$ 3,475.00

Blood Product Market by Type (Coagulation Factor, Immune Globulin, Albumin), By Application (Surgery, Therapy, Immunity) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2007

Report Code: EB_LS_463| Page: 77 | Published Date: July 2021
Add to cart
Quick view
Life Science

Cannabis Extraction Market Analysis and Global Forecast (2021-2027) with COVID Impact Analysis

$ 3,475.00

Cannabis Extraction Market By Type (Dry-Sieve Extraction, Water Extraction, Rosin Press Extraction, Isopropyl Oil or Quick-Wash ISO Extraction), By Application (Food, Medicine, Cosmetics, Others) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2027

Report Code: EB_LS_443 | Page: 93 | Published Date: June 2021
Add to cart
Quick view

Uncover Market Secrets: Get Market Insights in Your Inbox 🚀

Join over 5,000 professionals staying ahead of industry trends. Subscribe to our weekly market research newsletter.

Join our community of industry leaders and stay ahead of the curve. Subscribe now for data-driven market intelligence and strategic recommendations that will set your business on a path to success! Don't miss out on our FREE exclusive insights – sign up today and soar above your competition!🚀

cropped-evolvebi-Logo-2021-1.png
M/S Evolve Business Intelligence C-218, 2nd floor, M-Cube, N.H. – 48, Balitha, Vapi, Valsad- Gujarat
Email: [email protected]

Email: [email protected]

  • Important Links
    • About Evolvebi
    • Competitive Intelligence
    • Become a reseller
    • Contact Us
  • Top Search By Countries Hot
    • United State
    • Europe
    • Asia Pacific
    • Middle East & Africa
    • Latin America

© 2021 - 2023 Evolve Business Intelligence. All rights reserved. Developed by Nectron

Privacy Policy | Terms and Conditions | Cancellation and Refund policy

  • Home
  • About Us
  • Services
  • Market Reports
    • Automotive
      • Component
      • Vehicle
      • Chemical Automotive
      • Technology
      • Freight & Logistics
      • Material
      • Technology
      • Transport Mode
      • Utility
      • Vehicle
    • Chemical and Materials
      • Chemical
      • Advanced Materials
      • Coatings and Additives
      • Composites
      • Paints
      • Textile
    • Aerospace & Defense
      • Marine
      • Security
      • Technology
      • Aircraft Components
      • Aircraft Material
    • Construction & Manufacturing
    • Electronics and Semiconductor
      • Display Technology
      • Electronic Component
      • Electronic Devices
      • Semiconductor
      • Communication Equipment
      • Emerging Technologies
      • Security
      • Sensor & Control
      • Technology
    • Energy and Power
    • Life Science
    • Consumer & Goods
      • Baby products and supplies
      • Beauty & Personal Care
      • Consumer
      • Home Products
    • Information and Communication Technology
      • Emerging Technologies
      • Entertainment Technologies
      • Security
      • Communication
      • Data Center
      • Data Center and Networking
      • Software and Services
      • Technology
  • Competitive Intelligence (CI)
    • Automotive (CI)
    • Chemical and Materials (CI)
    • Construction & Manufacturing (CI)
    • Energy and Power (CI)
    • Electronics and Semiconductor (CI)
    • Healthcare (CI)
    • Information and Communication Technology ICT (CI)
  • Contact Us
We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.
More info Accept
I allow the Site owner to contact me via email/phone to discuss this enquiry. (If you want to know more about the way this site handles the data, then please go through our privacy policy).
Brought to you by WisdmLabs: WordPress Development Experts

Sending...